Yupei Zhang

Dr. Yupei Zhang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2024 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
CYChen Yu
Chen Yu
YZYupei Zhang
Yupei Zhang
SJShangyi Jin
Shangyi Jin
YWYanhong Wang
Yanhong Wang
QWQian Wang
Qian Wang
NJNan Jiang
Nan Jiang
Objectives: This study aimed at identifying risk factors for the incidence of interstitial lung disease in patients with rheumatoid arthritis (RA-ILD) by a systematic review and meta-analysis. Methods: Information sources: studies published by March 2021 were searched in PubMed, Web of Science, MEDLINE, EMBASE, Cochrane Library and Scopus databases. Eligibility criteria: cohort studies or nested case-control studies that reported OR or HR of risk factors for RA-ILD were included. Two researchers independently screened the studies and extracted data. Synthesis of results: the relative risks (RRs) were introduced to measure the association across studies. Risk bias: quality assessments of included studies were performed using the Newcastle-Ottawa Scale. Based on the result of heterogeneity, the random-effects model or fixed-effects model was chosen in the meta-analysis. Furthermore, a sensitivity analysis was conducted to identify the origins of heterogeneity, and publication bias was evaluated for the factors with no less than five included studies by funnel plots and Egger’s test. Results: Among 3075 identified articles, 12 studies met the inclusion criteria. 17 risk factors were included in the meta-analysis. Male (RR 1.94, 95% CI 1.33 to 2.85, p60 years, RR 1.42, 95% CI 1.05 to 1.94, p=0.02), older RA onset age (RR 1.05, 95% CI 1.01 to 1.10, p=0.02), smoking (RR 1.37, 95% CI 1.09 to 1.71, p=0.006), lung complications (RR 2.72, 95% CI 1.24 to 5.95, p=0.01), rheumatoid nodule (RR 1.85, 95% CI 1.36 to 2.51, p<0.001), leflunomide usage (RR 1.41, 95% CI 1.02 to 1.96, p=0.04) were identified as risk factors of RA-ILD. Conclusion: Physicians should be aware that patients with RA with the above risk factors are likely to develop RA-ILD, and perform close ILD screening during follow-ups so that the patients can be early diagnosed and treated, and achieve improved prognosis.

11 July 2026 in BMC Immunology
Verified
Journal Article
Open access
PDF file
QCQi Chen
Qi Chen
RCRuxuan Chen
Ruxuan Chen
YSYujie Shi
Yujie Shi
SWShiyang Wang
Shiyang Wang
ZLZhiyi Li
Zhiyi Li
CSChi Shao
Chi Shao
Good Syndrome (GS) is a rare immunodeficiency disorder classically defined by the triad of thymoma, hypogammaglobulinemia, and recurrent infections. Cytome

20 October 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
QCQi Chen
Qi Chen
RCRuxuan Chen
Ruxuan Chen
YSYujie Shi
Yujie Shi
SWShiyang Wang
Shiyang Wang
ZLZhiyi Li
Zhiyi Li
HHHui Huang
Hui Huang
Good Syndrome (GS) is a rare combined immunodeficiency syndrome characterized by the presence of thymoma, hypogammaglobulinemia, and opportunistic infectio